We measured total anti-SARS-CoV-2 receptor-biding domain (RBD) antibodies in 249 healthcare workers (mean age: 44 ± 13 years; 151 women), who received the first dose of mRNA-based Comirnaty COVID-19 vaccine at different times of the day. Compared with the reference vaccination time point (i.e. <10:00h), vaccine injection at the following times of day elicited a comparable response (all > 0.05). Under our experimental conditions, we can therefore exclude a possible influence of the timing of primary mRNA-based COVID-19 vaccination on the levels of total anti-SARS-CoV-2 antibodies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/07420528.2023.2298264 | DOI Listing |
Publication Analysis
Top Keywords
total anti-sars-cov-2
12
vaccination time
8
anti-sars-cov-2 antibodies
8
time influence
4
influence total
4
antibodies response
4
response measured
4
measured total
4
anti-sars-cov-2 receptor-biding
4
receptor-biding domain
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!